Slovakia CBD status in 2026: legal access is not full product compliance
Slovakia removed cannabidiol from its national narcotics list with effect from 1 May 2021, but this did not create a blanket exemption from EU product rules. For ingestible…
News · Europe CBD
Portugal is stricter than most EU CBD shops suggest. INFARMED treats cannabidiol as a medicinal substance, ASAE has seized retail oils, and ingestible CBD still lacks EU novel food authorisation.

CBD oils and gummies appear on Portuguese websites, but the national framework is narrow. Decree-Law 8/2019 and Ordinance 83/2021 place cannabis-derived preparations under INFARMED’s medicines regime. Cannabidiol marketed with wellness or therapeutic framing can be reclassified as a medicine, not a food supplement.
On top of medicines law, ingestible CBD sits under Regulation (EU) 2015/2283 on novel foods. No full EU authorisation exists for retail CBD foods or supplements. ASAE, Portugal’s food and economic safety authority, has removed CBD products from shops in past inspections when classification or paperwork failed.
EFSA’s provisional safe intake for high-purity CBD isolate (about 2 mg/day for a 70 kg adult, published 9 February 2026) is a risk-assessment reference. It is not a novel food approval and does not open a Portuguese retail lane for oils or gummies.
Spain and Germany still have visible grey-zone retail for CBD oils. Portugal layers INFARMED medicines sensitivity on top of the EU novel food block. Broad-spectrum or isolate labels alone do not fix the issue if the product is sold for ingestion.
Disclaimer: News context for shoppers, not legal or medical advice. INFARMED and ASAE practice can change. Check current official guidance before you buy, ship or sell CBD in Portugal.
You may find oils online, but ingestible CBD does not have a clean legal retail route. INFARMED medicines law and EU novel food non-authorisation both apply.
No clear retail lane exists. Gummies with CBD sit in the unauthorised novel food category and carry clear compliance risk.
No. EFSA's provisional intake is a risk-assessment reference for high-purity CBD supplements, not a novel food authorisation.
Medical Disclaimer
The information on this website is for general informational purposes only and does not constitute medical advice. CBD products are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before using CBD, especially if you are pregnant, nursing, taking medication, or have a medical condition.
CBD legality varies by country and region. In the EU, CBD products containing less than 0.2% THC are generally permitted, but local laws may differ. Verify the legal status in your jurisdiction before purchasing or using CBD products.
This website may contain affiliate links. We may earn a commission from qualifying purchases at no additional cost to you. Affiliate relationships do not influence our editorial content or product recommendations.
Last updated: August 2026